Form 4 for OPRX OptimizeRx Corp
Accepted 2024-06-12 00:00:00 ET · period of report 2024-04-18 · accession 0001628280-24-027755 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-12 | 2024-04-18 | OPRX | FEBBO WILLIAM J | CEO, Dir | M - OptEx | $0.00 | +28.9K | 582.0K | +5% | $0 |
| D | 2024-06-12 | 2024-04-18 | OPRX | FEBBO WILLIAM J | CEO, Dir | F - Tax | $9.35 | -782 | 581.3K | -0.1% | -$7,312 |
| D | 2024-06-12 | 2024-04-18 | OPRX | FEBBO WILLIAM J | CEO, Dir | M - OptEx | $0.00 | -28.9K | 57.8K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-18 | M | A | 28,895 | $0.00 | 582,035 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) The Reporting Person's prior holdings were previously inadvertently overstated by four shares. |
| 2 | Common | Common Stock | 2024-04-18 | F | D | 782 | $9.35 | 581,253 | D | — | — | (F3) These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended. |
| 3 | Derivative | Restricted Stock Units | 2024-04-18 | M | D | 28,895 | $0.00 | 57,790 | D | — · — to — | 28,895 Common | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) On April 18, 2023, the Reporting Person was granted 86,685 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. |